share_log
Benzinga ·  07/09 04:11

On Monday, Johnson & Johnson Agreed To Pay $50M To Settle Claims Related To A Terminated Manufacturing Deal With Emergent BioSolutions Related To Johnson & Johnson's Covid-19 Vaccine - 8K

周一,强生同意支付5千万美元,以解决与Emergent Biosolutions终止制造协议有关的索赔,涉及强生的covid-19生物-疫苗 - 8K

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发